Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
W. R. Teodoro, A. P. Velasa, D. dos Anjos, R. Konno, C. C. de Oliveira, M. L. Katayama, E. R. Parra, N. Yoshinari, V. L. Capelozzi (São Paulo, Brazil). Type V collagen nasal tolerance regulates collagen mRNA synthesis in pulmonary remodeling of experimental systemic sclerosis. Eur Respir J 2008; 32: Suppl. 52, 1892

Member's Comments

No comment yet.

Related content which might interest you: Collagen V nasal tolerance promotes decrease in topoisomerase-1 and pulmonary fibrosis of systemic sclerosis model Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis Year: 2010 Up-regulation of collagen type V mRNA in a model of systemic sclerosis Source: Annual Congress 2011 - Lung development and neoplasia Year: 2011 Refractory remodeling of intrapulmonary arteries by type V collagen, apoptosis and endothelial activation in experimental systemic sclerosis Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 Increased mRNA expression of collagen V gene in pulmonary fibrosis of systemic sclerosis Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009 Collagen V nasal tolerance reverts pulmonary immune cells proliferation and interstitium remodeling in experimental scleroderma Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007 Pulmonary interstitium remodeling by collagen V is associated with profibrotic cytocines in experimental systemic sclerosis Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007 Collagen V and decorin is involved in systemic sclerosis pulmonary fibrosis Source: Annual Congress 2011 - The ageing pulmonary interstitium Year: 2011 Abnormal collagen type V deposition in lung fibroblast is correlated with a worse pulmonary function in systemic sclerosis Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007 Nasal tolerance promotes increase in tumoral type V collagen protein synthesis and vascular apoptosis in the mouse lung chemical carcinogenesis Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010 Transcription factor FOXp3 is over expressed in BALT of systemic sclerosis model induced by collagen V nasal tolerance Source: Annual Congress 2011 - Animal models of airway inflammation Year: 2011 Arterial type V collagen disorganization in patients with systemic sclerosis: preliminary study Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007 Tridimensional reconstruction and biochemical profile of collagen V alpha-2 chain in lung fibroblasts culture from patients with systemic sclerosis indicate a defect in fibrillogenesis microarchitecture Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010 Pentastatin, matrikine of the type IV collagen a5 drives pulmonary hypertension via endothelial dysfunction Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension Year: 2021 Oral immunotherapy with type V collagen in idiopathic pulmonary fibrosis Source: Eur Respir J 2015; 45: 1393-1402 Year: 2015 Nintedanib and pirfenidone inhibit collagen synthesis and maturation at several regulatory levels Source: International Congress 2016 – ILD pathogenesis Year: 2016 Late stage of experimental pulmonary fibrosis is modulated by collagen V Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Systemic sclerosis patients‘ sera recognize collagen V in experimental scleroderma lung fibrosis Source: Annual Congress 2011 - The ageing pulmonary interstitium Year: 2011 Remodelling in the bronchi of patients with COPD: defective ECM deposition and repair by pulmonary fibroblasts Source: Annual Congress 2013 –Immunopathology of COPD: contribution of advancements of new therapeutic agents Year: 2013 Expression of hyaluronidase by interstitial myofibroblasts and epithelial cells is associated with fibrosis extension, clinical forms and pulmonary function stage in patients with systemic sclerosis Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Parameters of sIgE and sIgG4-autoAbs to lung elastin, collagen type III and myosin in bronchial asthma in association with chronic infection. Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases Year: 2019